The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

The clinical practice update offers 12 “best practice advice” statements on POEM to treat achalasia and other esophageal ...

“I am pleased to be joining Terns as we advance our lead oncology and obesity programs towards important clinical readouts later this year,” said Mr. Azelby. “I look forward to working with Terns’ ...

HC Wainwright issued their Q1 2026 EPS estimates for Outlook Therapeutics in a note issued to investors on Tuesday, February 18th. HC Wainwright analyst D. Tsao anticipates that the company will post ...

Policy makers should continue to provide clear rules of the road, increase transparency, apply more effective oversight, and ...

After the rejection of Lykos Therapeutics’ MDMA-based PTSD treatment tempered excitement for psychedelic therapeutics, a ...

Recursion Pharmaceuticals struggles with validation of REC-994 and competition in oncology. Read why RXRX stock is a hold ...

Thyroid cancer continues to be overdiagnosed, though the survival rate remains unchanged, according to a study published Feb. 5 in The Lancet Diabetes & Endocrinology. Here are five notes from the ...

In a randomized clinical trial in China, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms ...

A new congressionally mandated report examines how opioid and benzodiazepine prescribing between 2007 and 2019 impacted ...

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

Government webpages that were recently restored in response to a federal judge's order now include notes rejecting their ...